Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dr. Lal PathLabs has informed that it attached Transcript of Q1 FY25 Earnings Conference Call.
The above information is a part of company’s filings submitted to BSE.